Veracyte
VCYT
189 hedge funds and large institutions have $2.06B invested in Veracyte in 2020 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 75 increasing their positions, 48 reducing their positions, and 14 closing their positions.
1,925% more call options, than puts
Call options by funds: $1.32M | Put options by funds: $65K
171% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 14
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
56% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 48
40% more capital invested
Capital invested by funds: $1.47B → $2.06B (+$587M)
14% more funds holding
Funds holding: 166 → 189 (+23)
3.05% less ownership
Funds ownership: 116.3% → 113.25% (-3%)
Top Buyers
Top Sellers
VCYT Hedge Fund Activity: Q3 2020 in Review
189 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2020, worth a combined $2.06B — up 40% from $1.47B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new VCYT positions and 14 closed out — a net gain of 24 holders — while 75 added to existing stakes and 48 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $66.9M. The largest seller was Versant Venture Management, exiting entirely with an estimated $31.2M sold.
- 189 institutional investors held Veracyte (VCYT) as of Q3 2020, up from 166 in Q2 2020.
- Funds reported $2.06B of Veracyte stock for Q3 2020, up 40% quarter-over-quarter.
- 38 funds opened new Veracyte positions in Q3 2020 and 14 closed out, a net change of +24 holders.
- The largest Veracyte buyer in Q3 2020 was Wellington Management Group, an estimated $66.9M added.
- The largest Veracyte seller in Q3 2020 was Versant Venture Management, an estimated $31.2M sold.
Based on aggregated 13F filings for Q3 2020.